HACKENSACK, N.J., May 26, 2026 /PRNewswire/ -- Investigators from Hackensack Meridian John Theurer Cancer Center (JTCC)—part of the National Cancer Institute-designated Lombardi Comprehensive Cancer Center at Georgetown University—and Hackensack University Medical Center are reporting research findings at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. The meeting is the premier event for cancer professionals and takes place in Chicago from May 29 to June 2. Continue Readin

New co-developed product delivers a complete Tier 1 ADME panel coupled with best-in-class AI-driven human pharmacokinetic (PK) projection and integrated compound management —enabling scientists to make lead-optimization-quality decisions starting in hit identification BOSTON, May 26, 2026 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA) today announced that its Datapoints offering is launching ADME-One™, a fully integrated ADME platform for drug discovery teams co-developed with Tangible Scientifi

Emalex Biosciences to use data from research led by Cincinnati Children's to seek FDA approval for ecopipam, the first drug designed to treat children with motor and vocal tics CINCINNATI, May 26, 2026 /PRNewswire/ -- Continued use of a drug called ecopipam can cut the risk of relapse in half for children battling tics caused by Tourette syndrome (TS). That's the key finding published May 26, 2026, in JAMA Neurology describing the results of a recently completed phase III clinical trial of the f

NASHVILLE, Tenn., May 26, 2026 /PRNewswire/ -- Physicians affiliated with OneOncology partner practices and the OneOncology Research Network (OneR) will present 23 abstracts at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, held May 29 - June 2 in Chicago. Continue Reading OneR affiliated investigators will present abstracts at ASCO spanning a wide range of therapeutic approaches and tumor types, including lung, breast, gastrointestinal, genitourinary, hematologic malignan

The Fostering Effective Diagnosis and Treatment for Underserved Populations with Bleeding Disorders Act would expand research, provider education, and awareness of bleeding disorders in women and girls through coordinated federal action. NEW YORK, May 26, 2026 /PRNewswire/ -- Last week, Representatives Julie Johnson (D-TX-32), Joe Wilson (R-SC-02), and Sarah McBride (D-DE-At Large) introduced the Fostering Effective Diagnosis and Treatment for Underserved Populations with Bleeding Disorders Act

TOKYO and PALO ALTO, Calif., May 26, 2026 /PRNewswire/ -- bitBiome, a pioneering force in the field of discovery, design and engineering of novel enzymes, proteins, strains, and ingredients, today announced that it has closed an oversubscribed seed extension round. This investment underscores bitBiome's traction and global relevance in the engineering biology and bio-manufacturing landscape. With this investment, bitBiome is poised to accelerate its mission to discover and engineer microbial enz

Accepted ASCO abstracts highlight Mercy's blood-based lung cancer screening and lung nodule triage programs using specimens from the NLST biorepository, which was established to support validation of early detection lung cancer biomarkers WALTHAM, Mass., May 26, 2026 /PRNewswire/ -- Mercy BioAnalytics, Inc., a pioneer in blood-based early cancer detection, today announced that it will present two abstracts at the 2026 ASCO Annual Meeting highlighting results from studies using biospecimens from

STOCKHOLM, May 26, 2026 /PRNewswire/ -- Sobi® (STO: SOBI) today announced results from a new analysis of the pivotal Phase 3 CORE and CORE2 trials, showing Tryngolza® (olezarsen) reduced the relative risk of acute pancreatitis events by 85% (P<0.001) and reduced triglycerides by 66% in patients with severe hypertriglyceridemia (sHTG) after six months.[1] The pooled subgroup analysis, presented as a late breaking abstract at the European Atherosclerosis Society (EAS) 2026 Congress in Athens, Gree

DELRAY BEACH, Fla., May 26, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Veterinary PoC Diagnostics Market is projected to grow from about USD 1.19 billion in 2026 to USD 1.72 billion by 2031, at a CAGR of 7.7%. Browse through 420 market data tables and 65 figures spread across 450 pages and the in-depth TOC on the 'Veterinary PoC Diagnostics Market - Global Forecast to 2031' Veterinary PoC Diagnostics Market Size & Forecast: Market Size Available for Years: 2025–2031 2026 Market S

WFI manufacturing and other capabilities support for pharmaceutical innovation, GLP ‑ 1 therapies, and medical devices. LILLINGTON, N.C., May 26, 2026 /PRNewswire/ -- ILC Dover, an Ingersoll Rand business and world leader in the innovative design and production for biopharmaceutical, pharmaceutical, and medical device markets, recently invested in two new core capabilities—Water for Injection (WFI) quality water and custom chemical solutions. This is a significant expansion that further strength